Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation.
Ontology highlight
ABSTRACT: Elevated copper levels induce tumor cuproptosis and ferroptosis, leading to immunogenic cell death and subsequent antitumor immune responses. However, dysregulated copper metabolism in tumor cells maintains homeostatic copper balance, while hypoxic microenvironments hinder therapeutic efficacy. In this study, we present a nanozyme system, termed CussOMEp, comprising a copper-based nanovector (CussNV) that is PEGylated and loaded with omeprazole, a copper transporter inhibitor, to enhance tumor synergistic immunotherapy by promoting cuproptosis and ferroptosis. CussNV is assembled from dithiodiglycolic acid and copper ions, exhibiting peroxidase, glutathione oxidase, and catalase-like activities, along with responsive degradability. This nanozyme alleviates tumor hypoxia by producing oxygen
SUBMITTER: Gu L
PROVIDER: S-EPMC11909888 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA